Pure Bioscience, Inc. (PURE) Reports Q2 Loss of $0.05
Pure Bioscience,
Inc. (NASDAQ: PURE) reported Q2 EPS of ($0.05), versus ($0.07) reported last year. Revenue for the quarter came in at $221 thousand, versus $68 thousand reported last year.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
Inc. (NASDAQ: PURE) reported Q2 EPS of ($0.05), versus ($0.07) reported last year. Revenue for the quarter came in at $221 thousand, versus $68 thousand reported last year.For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.